Epigenetics & the future of Glioblastoma treatment

Epigenetics & the future of Glioblastoma treatment

Posted 22 October, 2021 at 09:09

Author Jessica McClory on behalf of In Sues Name


Glioblastoma treatment usually includes surgery, radiation and then chemotherapy. Unfortunately, these tumours almost inevitably adapt to evade the anti-cancer drugs that at first seemed to shrink them. New evidence shows that glioblastoma cells can change which genes they express, and when, in response to environmental stress. This stress could be being attacked with chemotherapy drugs. These are epigenetic changes because the cancer cells don’t change the genes themselves, instead, they seem to be chemically modifying their genes in response to this stress, covering them or uncovering them as necessary to survive. A new paper highlights a mechanism by which the tumour potentially adapts to our treatment methods and how, by understanding these evasion methods that the tumour utilises, we can more effectively neutralise them.

The full paper is in Nature Genetics

The role of epigenetics is key to the research undertaken at our Queen Mary University of London research centre and there is an opportunity for a graduate with at least an upper second class honours degree, an interest in Brain Tumourigenesis and experience in Molecular Biology, Cell Biology or Computer Science to join the Brain Tumour Research Centre of Excellence led by Prof Silvia Marino at the Blizard Institute. They will then form part of the team focused on the mechanistic characterisation of tumour defining epigenetic changes in glioblastoma subgroups and will study how they can inform precision targeting of these neoplasms.

More from In Sues Name

A new potential way to treat brain tumours is on the horizon...
Press Release

A new potential way to treat brain tumours is on the horizon...

26 November 2021
Vote for us to win a £1,000 donation this Christmas!
Press Release

Vote for us to win a £1,000 donation this Christmas!

24 November 2021
In Sue’s Name’s £1 million commitment to help find a cure for GBM
Press Release

In Sue’s Name’s £1 million commitment to help find a cure for GBM

22 November 2021
In Sue’s Name’s £1 million commitment to help find a cure for GBM
Press Release

In Sue’s Name’s £1 million commitment to help find a cure for GBM

18 November 2021
Card image cap
user

In Sues Name

Charity

Profile Feed
In Sue’s Name was founded in 2014 by David Taylor in memory of his beloved daughter Sue Blasotta, who died in 2011 of brain tumours. Sue was devoted to her husband Joe and their children Sasha and Daniel. She adored her career, first in recruitment with Reed Employment and then caring for ch...

32

Press Releases